Pagano Mario Angelo, Tibaldi Elena, Palù Giorgio, Brunati Anna Maria
Mario Angelo Pagano, Elena Tibaldi, Giorgio Palù, Anna Maria Brunati, Department of Molecular Medicine, University of Padua, Padua 35121, Italy.
World J Virol. 2013 May 12;2(2):71-8. doi: 10.5501/wjv.v2.i2.71.
To complete their life cycle and spread, viruses interfere with and gain control of diverse cellular processes, this most often occurring through interaction between viral proteins (VPs) and resident protein partners. Among the latter, Src family kinases (SFKs), a class of non-receptor tyrosine kinases that contributes to the conversion of extracellular signals into intracellular signaling cascades and is involved in virtually all cellular processes, have recently emerged as critical mediators between the cell's infrastructure and the viral demands. In this scenario, structural or ex novo synthesized VPs are able to bind to the different domains of these enzymes through specific short linear motifs present along their sequences. Proline-rich motifs displaying the conserved minimal consensus PxxP and recognizing the SFK Src homology (SH)3 domain constitute a cardinal signature for the formation of multiprotein complexes and this interaction may promote phosphorylation of VPs by SFKs, thus creating phosphotyrosine motifs that become a docking site for the SH2 domains of SFKs or other SH2 domain-bearing signaling molecules. Importantly, the formation of these assemblies also results in a change in the activity and/or location of SFKs, and these events are critical in perturbing key signaling pathways so that viruses can utilize the cell's machinery to their own benefit. In the light of these observations, although VPs as such, especially those with enzyme activity, are still regarded as valuable targets for therapeutic strategies, multiprotein complexes composed of viral and host cell proteins are increasingly becoming objects of investigation with a view to deeply characterize the structural aspects that favor their formation and to develop new compounds able to contrast viral diseases in an alternative manner.
为了完成其生命周期并传播,病毒会干扰并控制各种细胞过程,这通常是通过病毒蛋白(VPs)与驻留蛋白伴侣之间的相互作用来实现的。在后者中,Src家族激酶(SFKs)是一类非受体酪氨酸激酶,它有助于将细胞外信号转化为细胞内信号级联反应,并且几乎参与所有细胞过程,最近已成为细胞基础设施与病毒需求之间的关键介质。在这种情况下,结构型或新合成的VPs能够通过其序列中存在的特定短线性基序与这些酶的不同结构域结合。富含脯氨酸的基序显示出保守的最小共有序列PxxP并识别SFK的Src同源(SH)3结构域,构成了多蛋白复合物形成的主要特征,这种相互作用可能促进SFKs对VPs的磷酸化,从而产生磷酸酪氨酸基序,成为SFKs的SH2结构域或其他带有SH2结构域的信号分子的对接位点。重要的是,这些组装体的形成还会导致SFKs的活性和/或位置发生变化,而这些事件对于扰乱关键信号通路至关重要,从而使病毒能够利用细胞机制为自身谋利。鉴于这些观察结果,尽管VPs本身,尤其是那些具有酶活性的VPs,仍然被视为治疗策略的重要靶点,但由病毒和宿主细胞蛋白组成的多蛋白复合物越来越成为研究对象,以期深入表征有利于其形成的结构方面,并开发能够以另一种方式对抗病毒性疾病的新化合物。